Affymetrix' GeneTitan(TM) System Delivers Automatic Answers and Sets New Standard in Genomic Analysis.Industry's Most Cited Gene Expression Content Now Available in More Flexible, Affordable and Easier-to-Use Array Plate Formats SANTA CLARA Santa Clara, city, Cuba Santa Clara (sän`tä klä`rä), city (1994 est. pop. 217,000), capital of Villa Clara prov., central Cuba. , Calif. -- Affymetrix Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :AFFX) today announces the GeneTitan[TM] System, the only complete platform to automate customer workflow from target preparation through array processing Array processing is signal processing of the outputs of an array of sensors to:
intravenous transfusion. Express Assay, which uses a streamlined protocol and less starting material. Traditional microarray formats require a labor-intensive, manual handling process, and the only way to increase throughput is to add manpower, which results in higher costs and higher data variability. With the GeneTitan System, researchers can harness hands-free automation to minimize labor costs and improve data consistency Data consistency summarizes the validity, accuracy, usability and integrity of related data between applications and across the IT enterprise. This ensures that each user observes a consistent view of the data, including visible changes made by the user's own transactions and . This allows users to focus on analyzing data rather than laboratory bench work. Researchers can now take a whole-genome approach to expression profiling and smoothly scale up to process large numbers of samples. Additional plate-format applications will be available on the GeneTitan System in the future. "The new Affymetrix array plates offer a scalable solution using some of the industry's most widely cited gene expression array content," said Shawn Levy Shawn Adam Levy (born 1967) is a Canadian American director and actor. He was born in Montreal, Quebec. Levy is the director of Big Fat Liar, Just Married, Cheaper by the Dozen, The Pink Panther, and Night at the Museum. , Ph.D., assistant professor of biomedical informatics Biomedical informatics is a term used to describe the broad discipline that encompasses such subdomains as bioinformatics, clinical informatics, public health informatics, etc, and is most commonly used in this way in the USA[1]. and director of the Vanderbilt Microarray Shared Resource Sharing a peripheral device (disk, printer, etc.) among several users. For example, a file server and laser printer in a LAN are shared resources. Contrast with shared logic. . "The GeneTitan System's 24- and 96-array plate formats and the new automated array processing capabilities enable us to scale from low- to high-throughput projects more efficiently than before, with minimal user intervention." "Affymetrix has set a new standard in the whole-genome expression market with the launch of the GeneTitan System and by making the content found in the industry's most popular gene expression tools available in more scalable plate formats," said Kevin King, president of Affymetrix. "We expect customers to adopt this new smaller, higher-density and more flexible array format and automated platform over the next year, opening the door to many more genomic breakthroughs." Complete Microarray Processing Solution The GeneTitan System is built on the same content featured in GeneChip([R])cartridges, the industry standard in microarray research for the past decade. The complete platform includes new automated instrumentation, proven array content, optimized assays and reagents as well as open software architecture. The GeneTitan System includes: * GeneChip([R]) HT PM Array Plates--comprehensive coverage of the transcribed human, mouse and rat genomes, in a convenient configuration that enables researchers to interrogate either 24 or 96 distinct samples per plate. Each of the arrays in the new plates offers the same whole-genome content as the previous two-plate set. * GeneChip([R]) HT 3' IVT Express Assay--optimized target preparation kit for gene expression studies which is easier to use and requires less starting sample material than previous assays, enabling researchers to generate high-quality gene expression results faster and more cost effectively than before. * GeneChip([R]) Array Station--automated target preparation solution which allows one person to prepare the same number of targets as four people could accomplish manually. * GeneTitan Instrument--only fully integrated instrument which provides hands-free automation of array processing from hybridization hybridization /hy·brid·iza·tion/ (hi?brid-i-za´shun) 1. crossbreeding; the act or process of producing hybrids. 2. molecular hybridization 3. to data analysis, empowering users to focus on different experimental studies for a better understanding of biological systems. * Affymetrix([R]) GeneChip([R]) Command Console([R]) and Expression Console([TM]) software--scalable data management options for medium- and high-throughput projects with a convenient file-based format for data storage. The software easily integrates with laboratory information management systems to increase laboratory efficiency and productivity. For more information on the GeneTitan System, please visit: http://www.affymetrix.com/genetitan About Affymetrix Affymetrix GeneChip([R])microarray technology is the industry-standard tool for analyzing complex genetic information. After inventing microarray technology in the late 1980s, Affymetrix scientists have been dedicated to developing innovative products that provide researchers with a more complete view of the genome. These products continue to accelerate genetic research and enable scientists to develop diagnostics and tailor treatments for individual patients by identifying and measuring the genetic information associated with complex diseases. Today, Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , as well as leading academic, government and not-for-profit research institutes. More than 1,700 systems have been shipped around the world and more than 13,000 peer-reviewed papers have been published using the technology. Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing facilities in Sacramento, Calif., Cleveland, Ohio "Cleveland" redirects here. For the Cleveland metropolitan area, see . For other uses, see Cleveland (disambiguation). Cleveland is a city in the U.S. state of Ohio and the county seat of Cuyahoga County, the most populous county in the state. , and Singapore. The company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe and Asia. For more information about Affymetrix, please visit the company's website at www.affymetrix.com. Forward-looking Statements All statements in this press release that are not historical are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act as amended, including statements regarding Affymetrix' "expectations," "beliefs," "hopes," "intentions," "strategies" or the like. Such statements are subject to risks and uncertainties that could cause actual results to differ materially for Affymetrix from those projected, including, but not limited to: risks and uncertainties relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc commercial success of the Affymetrix GeneTitan[TM] System discussed in this press release; risks of the company's ability to achieve and sustain higher levels of revenue, higher gross margins and reduced operating expenses Operating expenses The amount paid for asset maintenance or the cost of doing business, excluding depreciation. Earnings are distributed after operating expenses are deducted. ; uncertainties related to technological approaches, manufacturing and product development; personnel retention; uncertainties related to cost and pricing of Affymetrix products; dependence on collaborative partners; uncertainties related to sole-source suppliers; risks associated with past and future acquisitions; uncertainties relating to FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory approvals; competition; risks relating to intellectual property of others and the uncertainties of patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . These and other risk factors are discussed in Affymetrix' Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 2007, and other SEC reports, including its Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. for subsequent quarterly periods. Affymetrix expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Affymetrix' expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. NOTE: Affymetrix, the Affymetrix logo and GeneChip([R]) are registered trademarks owned or used by Affymetrix Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion